{"version":"1.0","provider_name":"South Africa Gazette","provider_url":"https:\/\/southafricagazette.com","author_name":"shadmin","author_url":"https:\/\/southafricagazette.com\/author\/shadmin-s\/","title":"Adagio Therapeutics r\u00e9sume l\u2019activit\u00e9 neutralisante de l\u2019ADG20 contre les variants du SARS-CoV-2 et d\u00e9crit ses initiatives visant \u00e0 contrer Omicron - South Africa Gazette","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"horIU1AZKX\"><a href=\"https:\/\/southafricagazette.com\/adagio-therapeutics-resume-lactivite-neutralisante-de-ladg20-contre-les-variants-du-sars-cov-2-et-decrit-ses-initiatives-visant-a-contrer-omicron\/\">Adagio Therapeutics r\u00e9sume l\u2019activit\u00e9 neutralisante de l\u2019ADG20 contre les variants du SARS-CoV-2 et d\u00e9crit ses initiatives visant \u00e0 contrer Omicron<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/southafricagazette.com\/adagio-therapeutics-resume-lactivite-neutralisante-de-ladg20-contre-les-variants-du-sars-cov-2-et-decrit-ses-initiatives-visant-a-contrer-omicron\/embed\/#?secret=horIU1AZKX\" width=\"600\" height=\"338\" title=\"&#8220;Adagio Therapeutics r\u00e9sume l\u2019activit\u00e9 neutralisante de l\u2019ADG20 contre les variants du SARS-CoV-2 et d\u00e9crit ses initiatives visant \u00e0 contrer Omicron&#8221; &#8212; South Africa Gazette\" data-secret=\"horIU1AZKX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Des publications r\u00e9centes de plusieurs laboratoires ind\u00e9pendants montrent que l\u2019ADG20 a une activit\u00e9 neutralisante pr\u00e9sentant une puissance comparable \u00e0 d\u2019autres anticorps et qui reste active contre Omicron Plusieurs initiatives sont en cours pour traiter Omicron et les futurs variants potentiels du SARS-CoV-2 WALTHAM, Massachusetts, 14 janv. 2022 (GLOBE NEWSWIRE) \u2014 Adagio Therapeutics, Inc., (Nasdaq\u00a0: ADGI), [\u2026]"}